Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2020
Pharma News, 2020
Resverlogix Receives US FDA Breakthrough Therapy Designation for Apabetalone
CALGARY, Canada I February 03, 2020 - Resverlogix Corp.
Insmed Announces Positive Top-Line Results from Phase 2 WILLOW Study of INS1007 in Patients with Non-Cystic Fibrosis Bronchiectasis
BRIDGEWATER, NJ, USA I February 3, 2020 - Insmed Incorporated (Nasdaq.
UK withdrawal from the EU on 31 January 2020
The United Kingdom will formally leave the European Union on 31 January 2020 and will become a third country to the EU.
Gilead climbs as coronavirus drug shows efficacy, starts trial
Gilead has made progress in its effort to reposition failed Ebola drug remdesivir as a treatment for the coronavirus sweeping across China.
FDA approves first drug for treatment of peanut allergy for children
Today the U.
Bayer wins EU recommendation for prostate cancer drug
Bayer on Friday won an endorsement from the European Union’s drug regulator for its prostate cancer drug darolutamide, putting it on track for approval, as it takes on rival products by Pfizer and J...
Researchers identify possible new combination treatment for advanced melanoma
FINDINGSA study by researchers at the UCLA Jonsson Comprehensive Cancer Center suggests that using an immunotherapy drug called NKTR-214, also known as bempegaldesleukin, in combination with an infusi...
Takeda to sell nearly-new Shire plant with 200 employees
Takeda, which has been cutting costs after closing its $60 billion deal for Shire last year, is putting a Shire plant up for sale.
WHO Declares Coronavirus Outbreak A Global Health Emergency
The World Health Organization announced Thursday that the outbreak of a deadly and fast-spreading strain of coronavirus constitutes a global health emergency.
New drug candidate created by AI in ‘world first’
Exscientia and and Japanese company Sumitomo Dainippon have announced that a joint AI-developed drug has been initiated for the treatment of obsessive-compulsive disorder as an initial indication.
Nanoparticle helps eat away deadly arterial plaque
As many readers will already know, atherosclerotic plaque-deposits on the inner walls of arteries are a frequent cause of heart attacks and strokes.
Acceleron's pulmonary hypertension treatment meets main goal, shares soar 79%
(Reuters) - Acceleron Pharma Inc (XLRN.
65
66
67
68
69
70
71
72
73
